Loading
A phase 1/2 trial of epirubicin in triple-negative breast cancer, run by Liu Shu, now recruiting.
Paclitaxel Oral Solution in Triple Neagtive Breast Cancer Neoadjuvant Therapy: A Dose-Finding Study is a phase 1/2, interventional study registered as NCT07739485 by Liu Shu, with a registry enrolment figure of 30 participants, started 2026-07-30 and due to reach its primary completion in 2027-07-30. Interventions recorded: Epirubicin and cyclophosphamide followed by paclitaxel oral solution. Conditions listed: Triple -Negative Breast Cancer. Triple-negative eligibility wording from the registry: "Triple-negative breast cancer (TNBC) is defined as ER \<1%, PR \<1%, and HER2-negative \[IHC 0, IHC 1+, or IHC 2+ with FISH-negative\]". Sites: China. No results are recorded here; the registry entry is the source.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Epirubicin, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.
Shares Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites), Cytotoxic chemotherapy and the tag tnbc-deep-dive.